Contact Us   

Royal Brompton Hospital

Update: 2015/1/20      View:
  • Order Online
Introduction






Royal Brompton Hospital


 

Royal Brompton Hospital is the largest specialist heart and lung centre in the United Kingdom (UK). The hospital is part of Royal Brompton & Harefield NHS Foundation Trust, which includes Royal Brompton Hospital in Chelsea and Harefield Hospital near Uxbridge. Royal Brompton & Harefield NHS Foundation Trust is the largest specialist heart and lung centre in the UK and among the largest in Europe. The late Diana, Princess of Wales (1961-1997) used to visit patients at the hospital often.

 


In 2005 the trust took on a new CEO, Bob Bell, who had previously been president and CEO at the William Osler Health Centre in Canada.

In 2009 Royal Brompton & Harefield became a foundation trust inside the NHS, giving it new freedom to run its own finances and borrow money."Foundation trust". Royal Brompton & Harefield NHS Foundation Trust. Retrieved 2009-09-27.




On Monday 5 July 2010, the new National Institute for Health Research (NIHR) Respiratory Biomedical Research Unit (BRU) Clinical Research Facility opened at the Royal Brompton Hospital. Funded and supported by the NIHR and the Royal Brompton Hospital Charitable Trustees, the Respiratory BRU puts the Trust and its academic partner Imperial College London at the forefront of international research into the most challenging lung conditions. It aims to:


Develop research teams by creating six new Consortia in key advanced lung diseases to progress future research and improve treatment for patients.
Provide the core facilities, including the new Clinical Research Facility, needed by the Consortia to undertake their work.

Encourage greater participation from patients and the public on research projects.

Facilitate the training of health professionals in Advanced Lung Disease.





On Monday 15 November 2010, the new National Institute for Health Research (NIHR) Cardiovascular Biomedical ResearchUnit opened at Royal Brompton Hospital, a joint initiative with academic partner Imperial College London.

As part of the NIHR, the cardiovascular BRU puts the Trust and Imperial at the forefront of international research into the most challenging heart conditions.


Research at the cardiovascular BRU will concentrate on increasing the understanding of poor heart function in people living with cardiomyopathy (inherited heart muscle disease), arrhythmia (irregular heart-beat), coronary heart disease and heart failure. This will be achieved by:

·         Faster identification of genes linked to heart disease with a view to providing more personalised treatment for patients in the future.

·         Improving imaging techniques to diagnose patients more accurately and monitor any changes occurring in the heart.

·         Conducting clinical trials to investigate new treatments or advancements to improve current medical care.

·         Developing new techniques such as gene therapy and stem cell therapy.


In November 2011, Royal Brompton Hospital was named as one of only five hospitals in the country that will offer extracorporeal membrane oxygenation (ECMO) to adults in an initiative that positions England as one of the leading countries in the world for the provision of this treatment. The other hospitals are: Guy’s & St Thomas’ NHS Foundation Trust, Papworth Hospital NHS Foundation Trust, University Hospitals of Leicester NHS Trust and University Hospital of South Manchester NHS Foundation Trust. 

More Products